Op-ed: Below, British politician Crispin Blunt discusses an apparent mismatch between the UK’s public perception of psilocybin-assisted psychotherapy and Government policy that is stifling research and development in the field. Readers can learn more about Crispin Blunt by reading his bio at the footer of this article, and the underlying survey can be found on Drug Science‘s website.


Previous articleSilo Wellness Partners with Mushe Inc. to Establish First Legal Brick & Mortar Psychedelic and Functional Mushroom Shop in the Western Hemisphere
Next articlePTSF62 – Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas